The Latest: EU drug regulator approves new J&J vaccine plant

AMSTERDAM — The European Medicines Agency has approved a new manufacturing site for Johnson & Johnson’s COVID-19 vaccine, in a move that should boost production of the one-dose vaccine across the 27-nation EU.

Become a Subscriber!

You have read all of your free articles this month. Select a plan below to start your subscription today.

Already a subscriber? Login

Sign In

Print & Digital

Includes home delivery and FREE digital access when you sign up with EZ Pay

• $16.25 per month

Buy

Unlimited Digital Access

*Access via computer, tablet, or mobile device

• $9.95 per month

Buy

Click here for more options